skip to Main Content
IRBM - First Targeted Protein Degrader Begins Phase I Clinical Trial

First targeted protein degrader begins phase I clinical trial

Despite the fact that less than 20% of the proteome has enzymatic activity, most drug development efforts have so far focused on identifying enzymatic inhibitors. However, targeting a cell’s proteasomal machinery is now considered an effective area of research. As…


CHDI Foundation extends collaboration with IRBM to accelerate development of Huntington’s disease therapeutics

19th November 2018, Pomezia, Italy – IRBM, a global contract research organization (CRO), has strengthened its position in neurodegenerative disease research following an extension of its long-standing collaboration with CHDI Foundation, a nonprofit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that substantially improve the lives of those affected by Huntington’s disease (HD).

Medical Research IRBM

BIO-Europe 2018

November 5-7, 2018 Copenhagen, Denmark Come meet IRBM’s delegates in Copenhagen to learn more about how IRBM can support your drug discovery efforts. Drop us a line to request a meeting through our contact form or, when open, the PartneringONE…

Biopharm America IRBM

Biopharm America

September 5-6, Boston, USA Our Global VP of Sales and Marketing, Heidi Kingdon-Jones, will join delegates from all over the world at Biopharm America in Boston. To meet with Heidi and learn about IRBM’s capabilities, reach out to us through…

Medicinal Chemistry IRBM

International Symposium of Medicinal Chemistry

September 2-6, Ljubljana, Slovenia Our delegates, Dr. Jesus Maria Ontoria and Dr. Pier Giorgio Pacifici, will be attending the EFMC International Symposium of Medicinal Chemistry. If you’d like to learn more about what IRBM can do for your projects, or…

BIO International Convention 2018 IRBM

BIO International 2018

June 4-7, 2018 Boston, MA, United States IRBM will be attending the BIO International conference in Boston, MA, from June 4 to June 7. To learn more about how IRBM can support your drug discovery efforts, drop us a line…

Back To Top